drugset
drugset / Trial / NCT04161404

Pharmacometabolomics of Andrographis Paniculata And Metformin In Healthy Volunteers Under Fasting Condition

NCT04161404 ↗

Phase 1 Unknown 18 enrolled University of Malaya Ministry of Health, Malaysia · collab
RandomizedCrossoverOpen-labelOther

Summary

This study is a phase 1, open label, randomized, three-way crossover, single dose, oral- administration of Andrographis paniculata and Metformin in healthy volunteers under fasting condition. The study will demonstrate the pharmacokinetics profile and pharmacodynamic through metabolic pathway analysis for Andrographis paniculata and Metformin.

Timeline

Start
2019-08-21
Primary completion
2019-12-31
Completion
2020-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Andrographis Paniculata Traditional medicine (herbal / TCM) 1000 mg Oral
Subject Andrographis Paniculata Traditional medicine (herbal / TCM) 2000 mg Oral
Subject Metformin Small molecule 1000 mg Oral

Indications

No indication recorded.